Allergy management support service

Development and feasibility of an Allergy Management Support System (AMSS) for primary care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN36780877

Enrollment

120

Registered

2017-11-23

Start date

2010-02-01

Completion date

Unknown

Last updated

2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy: rhinitis, asthma, atopic dermatitis and food allergy Respiratory Allergy: rhinitis, asthma, atopic dermatitis and food allergy

Interventions

This study uses a cluster randomised controlled design. Participants are randomly allocated to one of two groups: the intervention or the control group. GPs in the intervention group receive Allergy M

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. General practitioners (GP) 2. Allergic patient or parent of allergic child with sIgE test

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

Measure	Time frame
Feasibility of the AMSS is assessed using the percentage of AMSS recommendations sent to the GP within 10 working days of the slgE testing.	—

Secondary

Measure	Time frame
There are no secondary outcome measures.	—

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 24, 2026